Walleye Capital’s HUMANIGEN, INC. HGEN Stock Holding History

Walleye Capital’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,976	Closed	-$21K	–	3661
2022 Q2	$21K	Buy	+11,976	New	+$26.9K	﹤0.01%	1904
2022 Q1	–	Sell	-153,968	Closed	-$573K	–	2737
2021 Q4	$573K	Buy	153,968 +132,705	+624%	+$776K	0.02%	901
2021 Q3	$126	Sell	21,263 -38,737	-65%	-$544K	﹤0.01%	1283
2021 Q2	$1.04K	Sell	60,000 -31,206	-34%	-$569K	0.04%	439
2021 Q1	$1.74K	Buy	+91,206	New	+$1.66M	0.1%	171

Other funds holding HGEN

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital's HGEN Position: Q3 2022 in Review

Walleye Capital sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 11,976 shares — an estimated $21K sold.

Walleye Capital first reported a position in HGEN in Q1 2021 and held it in 5 quarters. The position peaked at $573K in Q4 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

Walleye Capital reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
Walleye Capital sold 11,976 HUMANIGEN, INC. shares in Q3 2022, an estimated $21K.
Walleye Capital first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 5 quarters.
Walleye Capital's HUMANIGEN, INC. position peaked at $573K in Q4 2021.
53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.